Allegra Allergy, Travel Basix Tablet, Film Coated
NDC Package 66715-6507-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Allegra Allergy, Travel Basix (fexofenadine hydrochloride) tablets is adults and children 12 years of age and overtake one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hourschildren under 12 years of agedo not useadults 65 years of age and olderask a doctorconsumers with kidney diseaseask a doctor. This formulation utilizes a tablet, film coated delivery system. Marketed by Lil' Drug Store Products, Inc, this product is identified by NDC 66715-6507 and is authorized under FDA application NDA020872.

Identification & Billing

NDC Package Code
66715-6507-2
Package Description
2 BLISTER PACK in 1 CARTON / 1 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
66715-6507
11-Digit Billing Format
66715650702
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Allegra Allergy, Travel Basix
Non-Proprietary Name
Fexofenadine Hydrochloride
Substance Name
Fexofenadine Hydrochloride
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
FEXOFENADINE HYDROCHLORIDE 180 mg/1
Pharmacologic Class
Usage Information
Adults and children 12 years of age and overtake one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hourschildren under 12 years of agedo not useadults 65 years of age and olderask a doctorconsumers with kidney diseaseask a doctor

Regulatory & Marketing

Labeler Name
Lil' Drug Store Products, Inc
Product Type
Human Otc Drug
FDA Application #
NDA020872
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-11-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66715-6507-2 identifies a specific commercial package of 2 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack of Allegra Allergy, Travel Basix, a human over the counter drug labeled by Lil' Drug Store Products, Inc. This tablet, film coated is formulated for oral use and contains fexofenadine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lil' Drug Store Products, Inc on October 11, 2022. The current certification is valid through December 31, 2027.

How is this Lil' Drug Store Products, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66715650702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
66715-6507-2
11-Digit CMS (5-4-2)
66715-6507-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.